Louise von Stechow

Louise von Stechow Speaking Topics

• ARTIFICIAL INTELLIGENCE IN PHARMA – BETWEEN HOPE, HYPE, AND FEAR

  AI is everywhere—it brings hopes of accelerating industrial processes and making our lives easier and our work more efficient. It also brings fears of inexplicable black-box calculations, unintended consequences, and the loss of human jobs.

  In the pharmaceutical industry, AI opens up the possibility of developing medications more quickly and tailoring them more precisely to the needs of individual patients. But to truly revolutionize the multibillion-dollar process of drug development using AI, this requires the right strategies, technological foundations, and, above all, high-quality data.

  In this keynote, Louise von Stechow explores the potential of AI beyond the hype and draft scenarios of what AI-driven drug development could look like.

• STORY HEROES – WHAT BIOTECH FOUNDERS CAN LEARN FROM FICTION WRITERS

  We’ve all experienced this situation—we stand on stage with beautifully crafted slides, a strong data package, and a well-practiced talk. We hope to wow our audience during an investor presentation or at a scientific conference. But we feel the audience’s attention slipping.

  What’s missing from our presentation?

  Story.

  A story with a clear motivation, high stakes, and our secret power to find a solution. Learn the storytelling formula from professional storytellers—from Aristotle to the makers of "Breaking Bad"—and elevate your data-heavy presentation into a story your audience will binge.

  By the end of the keynote, Louise von Stechow will have introduced the key formula for storytelling and convinced you that you are the protagonist in your biotech’s quest.

• THE FUTURE OF MEDICINE – TRENDS, TECHNOLOGIES, AND SKILLS

  What will the medicine of the future look like? Healthcare and medicine are on the verge of transformative change, driven by new technologies such as artificial intelligence, telemedicine, and wearable devices.

  Alongside the technologization and virtualization of medicine, there is a shift from reactive “fix the broken” approaches to preventive strategies and from one-size-fits-all treatments to personalized medicine.

  In this future, human healthcare professionals and machines will work hand in hand to deliver the best possible care, with empowered patients acting as equal decision-makers who understand and access their own healthcare data. However, a darker scenario could see medicine becoming fully industrialized and dehumanized.

  In this keynote, Louise outlines the key trends shaping the future of medicine and discusses the opportunities and risks that accompany these developments.

• LONGEVITY – THE DREAM OF ETERNAL LIFE

  What if aging weren’t inevitable? In this thought-provoking keynote, Louise von Stechow explores how cutting-edge biotechnology, genetic research, and AI are reshaping our understanding of aging—not as a natural decline but as a process that can be slowed, altered, or even reversed. From the work of pioneering companies like Altos Labs to the ethical and societal questions raised by radically extended lifespans, this keynote blends deep scientific insight with a broader cultural lens. It is designed to challenge assumptions, inspire new perspectives, and equip your audience with a clear understanding of where longevity science is headed—and what it means for us all. By the end of the keynote, the audience won’t just be asking “Can we live longer?”—they’ll be asking “How will we live differently if we do?”

• NEW TECH, NEW TALENT, NEW CHALLENGES – BIOTECH LEADERSHIP IN THE AGE OF AI

  Artificial intelligence feels omnipresent—especially since large language models like ChatGPT have entered our personal devices and workflows. In healthcare, pharma, biotech, and MedTech, AI has sparked extraordinary hopes: faster drug discovery, smarter diagnostics, and more personalized medicine.

  Yet ten years into the so-called AI revolution, with billions invested and over 100 AI-discovered molecules in clinical trials, the results remain mixed. Industry leaders face a challenging paradox: enormous potential on the one hand and persistent uncertainty on the other.

  In this keynote, we take a grounded look at the true state of AI in biotech and pharma. We’ll unpack:

  • What’s working, what’s still aspirational and the technological, regulatory, and cultural frictions slowing adoption.
  • Why strategic entry—even on a small scale—is essential to build internal AI literacy and resilience

  By the end of the keynote, the audience will gain a clear-eyed perspective on how to cut through the hype and move toward thoughtful, strategic adoption—positioning AI not as a buzzword but as a catalyst for real innovation.